Anticorps Recombinant de lapin anti-CD30 Ligand/TNFSF8

CD30 Ligand/TNFSF8 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

241831D9

N° de cat : 98253-1-PBS

Synonymes

TNFSF 8, CD30 L, TNFSF8, 241831D9, CD30LG



Informations sur le produit

98253-1-PBS cible CD30 Ligand/TNFSF8 dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Protéine recombinante
Nom complet tumor necrosis factor (ligand) superfamily, member 8
Masse moléculaire calculée 234 aa, 26 kDa
Numéro d’acquisition GenBankBC093630
Symbole du gène TNFSF8
Identification du gène (NCBI) 944
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C.

Informations générales

CD30 Ligand (CD30L), also named as TNFSF8 or CD153, is a type II transmembrane protein that belongs to the tumor necrosis factor (TNF) superfamily (PMID: 8391931). It is expressed on the surface of activated T cells, B cells, monocytes, macrophages, eosinophils, neutrophils, and mast cells (PMID: 26090498). CD30L interacts with its receptor, CD30, which is a cell surface protein expressed on a small subset of activated T and B lymphocytes, and a variety of lymphoid neoplasms, with the highest expression in classical Hodgkin lymphoma and anaplastic large cell lymphomas (PMID: 28885612). The CD30/CD30L signaling is involved in pleiotropic downstream effects including differentiation, cell survival and death, NFkB activation, and production of cytokines (PMID: 38534788).

{{ptg:RelatedPrimaryAntibodies}}